The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiple receptors for dopamine
Kebabian, J. W., & Calne, D. B. (1979) · Nature · doi:10.1038/277093a0 · Cited by 3,725
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Antipsychotic drug doses and neuroleptic/dopamine receptors
SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622
Kebabian, J. W., Petzold, G. L., & Greengard, P. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.8.2145 · Cited by 1,022
Quantitative Analysis of D2 Dopamine Receptor Binding in the Living Human Brain by PET
Farde, L., Hall, H., Ehrin, E., & Sedvall, G. (1986) · Science · doi:10.1126/science.2867601 · Cited by 831
Self-citationImaging Dopamine Receptors in the Human Brain by Positron Tomography
Wagner, H. N., Burns, H. D., Dannals, R. F., Wong, D. F., Langstrom, B., Duelfer, T., Frost, J. J., Ravert, H. T., Links, J. M., Rosenbloom, S. B., et al. (1983) · Science · doi:10.1126/science.6604315 · Cited by 741
SCH 23390—The first selective dopamine D-1 antagonist
Hyttel, J. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90381-3 · Cited by 737
Billard, W., Ruperto, V., Crosby, G., Iorio, L. C., & Barnett, A. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90540-x · Cited by 567
(1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.12.1518 · Cited by 541
Köhler, C., Hall, H., Ögren, S.-O., & Gawell, L. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90778-6 · Cited by 505
Cited by
Dopamine in schizophrenia: a review and reconceptualization
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.11.1474 · Cited by 2,018
The principal features and mechanisms of dopamine modulation in the prefrontal cortex
Seamans, J. K., & Yang, C. R. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.05.006 · Cited by 1,592
Farde, L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820070032005 · Cited by 1,419
Self-citationD1 Dopamine Receptors in Prefrontal Cortex: Involvement in Working Memory
Sawaguchi, T., & Goldman-Rakic, P. S. (1991) · Science · doi:10.1126/science.1825731 · Cited by 1,364
Ametamey, S. M., Honer, M., & Schubiger, P. A. (2008) · Chemical Reviews · doi:10.1021/cr0782426 · Cited by 1,271
Synthesis and Evaluation of 11C-Labeled 6-Substituted 2-Arylbenzothiazoles as Amyloid Imaging Agents
Mathis, C. A., Wang, Y., Holt, D. P., Huang, G.-F., Debnath, M. L., & Klunk, W. E. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030026b · Cited by 979
Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET
Okubo, Y., Suhara, T., Suzuki, K., Kobayashi, K., Inoue, O., Terasaki, O., Someya, Y., Sassa, T., Sudo, Y., Matsushima, E., et al. (1997) · Nature · doi:10.1038/385634a0 · Cited by 710
Seamans, J. K., Floresco, S. B., & Phillips, A. G. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-04-01613.1998 · Cited by 474
Dopamine Partial Agonists: A New Class of Antipsychotic
Lieberman, J. A. (2004) · CNS Drugs · doi:10.2165/00023210-200418040-00005 · Cited by 340
D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics
Farde, L., Wiesel, F. A., Nordstr�m, A. L., & Sedvall, G. (1989) · Psychopharmacology · doi:10.1007/bf00442555 · Cited by 325
Self-citationMechanisms of action of atypical antipsychotic drugs
Deutch, A. Y., Moghaddam, B., Innis, R. B., Krystal, J. H., Aghajanian, G. K., Bunney, B. S., & Charney, D. S. (1991) · Schizophrenia Research · doi:10.1016/0920-9964(91)90030-u · Cited by 253
Nagai, T., Takuma, K., Kamei, H., Ito, Y., Nakamichi, N., Ibi, D., Nakanishi, Y., Murai, M., Mizoguchi, H., Nabeshima, T., et al. (2007) · Learning & Memory · doi:10.1101/lm.461407 · Cited by 184
The role of neuromodulators in selective attention
Noudoost, B., & Moore, T. (2011) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.10.006 · Cited by 161
D1 dopamine receptor binding in mood disorders measured by positron emission tomography
Suhara, T., Nakayama, K., Inoue, O., Fukuda, H., Shimizu, M., Mori, A., & Tateno, Y. (1992) · Psychopharmacology · doi:10.1007/bf02253582 · Cited by 163
Developmental imaging genetics: Linking dopamine function to adolescent behavior
Padmanabhan, A., & Luna, B. (2014) · Brain and Cognition · doi:10.1016/j.bandc.2013.09.011 · Cited by 87
Winstanley, C. A., Zeeb, F. D., Bedard, A., Fu, K., Lai, B., Steele, C., & Wong, A. C. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.02.044 · Cited by 84
Jucaite, A., Forssberg, H., Karlsson, P., Halldin, C., & Farde, L. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.01.034 · Cited by 67
Self-citationImpairments of exploration and memory after systemic or prelimbic D1-receptor antagonism in rats
Clausen, B., Schachtman, T. R., Mark, L. T., Reinholdt, M., & Christoffersen, G. R. J. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.03.069 · Cited by 41
Dunn, M. J., & Killcross, S. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0488-y · Cited by 21
Norman, A. B., Tabet, M. R., Norman, M. K., Fey, B. K., Tsibulsky, V. L., & Millard, R. W. (2011) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.183244 · Cited by 10
Metadata
- Authors
- Farde, L., Halldin, C., Stone-Elander, S., & Sedvall, G.
- Venue
- Psychopharmacology
- Published
- 1987-07
- Volume
- 92
- Issue
- 3
- Pages
- 278-284
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2044469843
- Cited by
- 283
- References
- 34
- FWCI
- 7.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.